Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2009
08/27/2009WO2009104802A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
08/27/2009WO2009104200A1 A method for preparation of thiazolidinedione derivatives
08/27/2009WO2009104159A1 Oxazolidinone derivatives
08/27/2009WO2009104155A1 2-aza-bicyclo[2.2.1]heptane derivatives
08/27/2009WO2009103739A1 Heterocyclic inhibitors of stearoyl-coa desaturase
08/27/2009WO2009103652A1 Modulators for amyloid beta
08/27/2009WO2009103650A1 Sulfonamide compounds and their use as fungicide
08/27/2009WO2009082526A3 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation
08/27/2009WO2009074231A3 Insecticidal imino heterocycles
08/27/2009WO2009064752A3 Heterocyclic derivatives as modulators of ion channels
08/27/2009WO2009026248A3 Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase
08/27/2009WO2009012280A3 Benzimidazole poly(adp-ribose)polymerase inhibitors
08/27/2009US20090216027 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
08/27/2009US20090216024 Processes for making pioglitazone and compounds of the processes
08/27/2009US20090216016 Salt of proline derivative, solvate thereof, and production method thereof
08/27/2009US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes
08/27/2009US20090215834 Heterocyclic inhibitors of mek and methods of use thereof
08/27/2009US20090215827 Inhibitors of cxcr2
08/27/2009US20090215795 Cyclic amidine derivatives
08/27/2009US20090215790 Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof
08/27/2009US20090215766 Tetracyclic inhibitors of janus kinases
08/27/2009US20090215759 Modulators for amyloid beta
08/27/2009US20090215758 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs
08/27/2009US20090215757 Process for Preparation of High-Purity Meloxicam and Meloxicam Potassium Salt
08/27/2009US20090215749 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
08/27/2009CA2716515A1 Amine and ether compounds which modulate the cb2 receptor
08/27/2009CA2716349A1 Methods for inhibiting drug degradation
08/27/2009CA2716348A1 Diamide inhibitors of cytochrome p450
08/27/2009CA2716347A1 Amino acid inhibitors of cytochrome p450
08/27/2009CA2715947A1 Heterocyclic inhibitors of stearoyl-coa desaturase
08/27/2009CA2715872A1 Benzodiazepine compound and pharmaceutical composition
08/27/2009CA2714743A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
08/27/2009CA2714215A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
08/27/2009CA2713716A1 Modulators for amyloid beta
08/27/2009CA2713187A1 Oxazolidinone derivatives
08/27/2009CA2713184A1 2-aza-bicyclo[2.2.1]heptane derivatives
08/26/2009EP2093220A2 Inhibitors of fatty acid amide hydrolase
08/26/2009EP2091947A2 Glucokinase activators
08/26/2009EP2091945A1 Novel inhibitors of glutaminyl cyclase
08/26/2009EP2091940A2 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
08/26/2009EP2091937A2 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/26/2009EP2091936A1 Therapeutic agents useful for treating pain
08/26/2009EP2091916A2 L-phenylalanine derivatives and their use as integrin antagonists
08/26/2009EP1773817B1 Substituted aryl-amine derivatives and methods of use
08/26/2009EP1745033A4 4,5-disubstituted-2-aryl pyrimidines
08/26/2009EP1646615B1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
08/26/2009EP1603899B1 Heterocyclic urea derivatives for the treatment of pain
08/26/2009EP1539700B1 8-hydroxy quinoline derivatives
08/26/2009EP1173441B1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
08/26/2009CN101516878A Thiadiazole compound and use thereof
08/26/2009CN101516877A 杂环有机化合物 Heterocyclic compounds
08/26/2009CN101516875A CGRP receptor antagonists
08/26/2009CN101516871A Novel pyridazine derivatives
08/26/2009CN101516868A Novel pyridazine derivatives
08/26/2009CN101516849A 5-phenyl-nicotinamide derivatives
08/26/2009CN101514200A Compound of aztreonam and a synthetic method thereof
08/26/2009CN101514191A Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
08/26/2009CN101513402A Antiviral agent
08/26/2009CN100532381C Antineoplastic compound, medicament composition and use thereof
08/26/2009CN100532370C Acylaminothiazole derivatives, their preparation and their use as inhibitor for producing beta starchy peptide
08/25/2009US7579479 Modulators of blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid (NEFA) levels; hypoglycemia
08/25/2009US7579477 Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof
08/25/2009US7579470 3-(4-Chloro-phenyl)-2-methyl-2,4,5,6,7,8-hexahydro-1,2,6-triaza-azulene; serotonin receptor modulator; anxiolytic, antidepressant, antiinflammatory agent, analgesic; psychological, sleep, eating, bipolar, sexual disorders; schizophrenia, obesity, retinopathy
08/25/2009US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/25/2009US7579465 For treatment of picornavirus infections in mammals
08/25/2009US7579366 Epothilone derivatives and their synthesis and use
08/25/2009US7579363 Bicyclic compounds and compositions as PDF inhibitors
08/25/2009US7579357 Antidiabetic agents; obesity; controlling appetite
08/25/2009US7579355 Inhibitors of Akt activity
08/25/2009US7579352 Retinoic acid mimetic anilides
08/25/2009US7579349 anticarcinogenic agent 5-Chloro-2-{2-[3-(pyrid-2-yl)isoxazol-5-yl]pyrrolidin-1-yl}-4-(5-methyl-1H-pyrazol-3-ylamino)pyrimidine; chemical synthesis; use in modulating insulin-like growth factor 1 receptor activity
08/25/2009US7579347 Vanilloid receptor ligands and their use in treatments
08/25/2009US7579091 White electroluminescent polymeric material and preparation thereof
08/25/2009CA2383466C Aromatic nitrogen-containing 6-membered cyclic compounds
08/25/2009CA2366932C Cyclic protein tyrosine kinase inhibitors
08/25/2009CA2326815C Process for preparation of pyridine derivatives
08/20/2009WO2009103007A2 Steroid hormone receptor modulator compounds and methods
08/20/2009WO2009102325A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors
08/20/2009WO2009102226A1 Malonic acid salt of 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- 2,4-thiazolidinedione
08/20/2009WO2009101082A1 Substituted sulfonic acid amide compounds
08/20/2009WO2009101079A1 Pyrimidylmethyl sulfonamide compounds
08/20/2009WO2009101078A1 Pyrimidylmethyl sulfonamide compounds
08/20/2009WO2009101022A1 Heterocyclic antiviral compounds
08/20/2009WO2009100827A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
08/20/2009WO2009100571A1 A method for the separation and purification of epothilones
08/20/2009WO2009068214A3 Heteroaryl-substituted piperidines
08/20/2009WO2009037244A3 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
08/20/2009US20090209734 Peptidyl prodrugs and linkers and stabilizers useful therefor
08/20/2009US20090209590 Histone Deacetylase and Tubulin Deacetylase Inhibitors
08/20/2009US20090209588 Novel compounds, their preparation and use
08/20/2009US20090209583 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
08/20/2009US20090209563 Pyridinoylpiperidines as 5-HT1F agonists
08/20/2009US20090209554 Thiazoliums as transketolase inhibitors
08/20/2009US20090209542 mitogen activated protein kinase inhibitors; 4-(2-Fluoro-4-(methylthio)phenylamino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
08/20/2009US20090209533 Aldh-2 inhibitors in the treatment of addiction
08/20/2009US20090209532 Pharmaceutical compounds
08/20/2009US20090209522 Heterocyclic Non-Peptide GNRH Antagonists
08/20/2009DE102008008838A1 Cycloalkoxy-substituierte 4-Phenyl-3,5-dicyanopyridine und ihre Verwendung Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their use
08/20/2009CA2715839A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors
08/20/2009CA2714656A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
1 ... 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 ... 628